ENTITY
Takeda Pharmaceutical

Takeda Pharmaceutical (4502 JP)

233
Analysis
Health CareJapan
Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.
more
bullishToyota Motor
26 Jun 2018 08:51

Toyota for Bears: How Attractive Are Income Yields?

Toyota’s current dividend and buyback yields are 3.1% and 2.1% respectively (at the current market price of JPY7,199 as of 22nd June 2018) bringing...

Logo
145 Views
Share
04 Jun 2018 08:47

Japan: Sectors/Peer Groups 3M🔺Too Early to Bottom-Fish Cyclicals •Time to Trim Personal Products

THREE-MONTH % CHANGE IN SECTORS & PEER GROUPS - This regular insight focuses on the percentage change in each sectors' weight in the market...

Logo
136 Views
Share
28 May 2018 18:08

Japan: Scoring Results & Forecasts - Part 3 - Company Winners & Losers

INTRODUCTION - The final part of our Results and Forecast/Revision Scores review will look at the leading and lagging performers and forecasters...

Logo
269 Views
Share
16 May 2018 09:05

Takeda FVE Reduction Leaves Shares Slightly Undervalued; Shire Acquisition Neutral to Valuation

We’ve slightly lowered our Takeda Pharmaceutical Co Ltd (4502 JP) fair value estimate to JPY 5,100 from JPY 5,400 after incorporating the close of...

Logo
205 Views
Share
15 May 2018 00:29

Takeda FY17 Earnings - First Glance

Takeda Pharmaceutical Co Ltd (4502 JP) reported FY17 results on May 14, 2018 As anticipated, Entyvio (YoY 35.9% to ¥196.6b), Takecab (YoY 61.7% to...

x